A detailed history of Pnc Financial Services Group, Inc. transactions in Annexon, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 216 shares of ANNX stock, worth $1,518. This represents 0.0% of its overall portfolio holdings.

Number of Shares
216
Previous 161 34.16%
Holding current value
$1,518
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$4.33 - $6.79 $238 - $373
55 Added 34.16%
216 $1,000
Q4 2023

Feb 09, 2024

SELL
$1.63 - $4.63 $1,779 - $5,055
-1,092 Reduced 87.15%
161 $0
Q3 2023

Nov 13, 2023

SELL
$2.13 - $3.84 $291 - $526
-137 Reduced 9.86%
1,253 $2,000
Q2 2023

Aug 11, 2023

BUY
$2.1 - $6.37 $2,263 - $6,866
1,078 Added 345.51%
1,390 $4,000
Q2 2022

Aug 12, 2022

BUY
$2.11 - $4.06 $658 - $1,266
312 New
312 $1,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $335M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.